Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer
NCT01354379
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
125
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult Volunteers
Interventions
BIOLOGICAL:
NB-1008
BIOLOGICAL:
Fluzone IN
Sponsor
NanoBio Corporation